Molecule Information
General Information of the Molecule (ID: Mol02204)
Name |
Metastasis associated lung adenocarcinoma transcript 1 (MALAT1)
,Rattus norvegicus
|
||||
---|---|---|---|---|---|
Synonyms |
MALAT1
Click to Show/Hide
|
||||
Molecule Type |
LncRNA
|
||||
Gene Name |
MALAT1
|
||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Insulin recombinant
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Type 2 diabetes mellitus | [1] | |||
Resistant Disease | Type 2 diabetes mellitus [ICD-11: 5A11.0] | |||
Resistant Drug | Insulin recombinant | |||
Molecule Alteration | Down-regulation | Expression |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vivo Model | Male C57BL/6J mouse model | Mus musculus | ||
Experiment for Molecule Alteration |
RAP-PCR; qRT-PCR | |||
Mechanism Description | The overall metabolic impact of the absence of Malat1 on adipose tissue accretion and glucose intolerance is either physiologically not relevant upon aging and obesity, or that it is masked by as yet unknown compensatory mechanisms. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.